. Engineering neprilysin activity and specificity to create a novel therapeutic for Alzheimer's disease. PLoS One. 2014;9(8):e104001. Epub 2014 Aug 4 PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.